Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Adage Capital Management

Founders Phillip Gross Robert George Atchinson

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 105
Average round size
info
The average size of a deal this fund participated in
$94M
Portfolio companies 83
Rounds per year 4.57
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.18
Exits 51
Key employees 4
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
Summary

The venture was found in North America in United States. The main office of represented VC is situated in the Boston.

The standard case for the fund is to invest in rounds with 8-9 partakers. Despite the Adage Capital Management, startups are often financed by Morgenthaler Ventures, QuestMark Partners, Lightspeed Venture Partners. The meaningful sponsors for the fund in investment in the same round are Rock Springs Capital, T. Rowe Price, OrbiMed. In the next rounds fund is usually obtained by Redmile Group, Morgenthaler Ventures, SightLine Partners.

The real fund results show that this VC is 4 percentage points less often commits exit comparing to other companies. Opposing the other organizations, this Adage Capital Management works on 33 percentage points more the average amount of lead investments. The common things for fund are deals in the range of 50 - 100 millions dollars. The important activity for fund was in 2015. Despite it in 2019 the fund had an activity. The typical startup value when the investment from Adage Capital Management is more than 1 billion dollars. The fund is constantly included in 2-6 investment rounds annually. The top amount of exits for fund were in 2014.

Among the most popular portfolio startups of the fund, we may highlight AveXis, Tanium, MuleSoft. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Medical, Biotechnology. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager.

The fund was created by Phillip Gross, Robert George Atchinson. The overall number of key employees were 4.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Adage Capital Management:
Typical Co-investors
Adage Capital Management is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Adage Capital Management:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Menlo Micro

Consumer Electronics
Electronics
Hardware
Power Grid
Semiconductor
$150M09 Mar 2022 Irvine, California, United States

Scout Bio

Biotechnology
Health Care
Therapeutics
$33M19 Oct 2021 Philadelphia, Pennsylvania, United States

Pyramid Biosciences

Biotechnology
Life Science
$33M15 Oct 2021 Massachusetts, United States

Beckley Psytech

Health Care
Medical
Pharmaceutical
$79M15 Aug 2021 South Oxfordshire, England, United Kingdom

SiMa.ai

Artificial Intelligence
Machine Learning
Software
$80M11 May 2021 San Jose, California, United States

Arch Oncology

Biotechnology
$105M27 Apr 2021 California, United States

Biotechnology
Health Care
Information Technology
Pharmaceutical
Travel
$100M13 Apr 2021 New York, New York, United States

Antios Therapeutics

Biopharma
Biotechnology
Therapeutics
$96M12 Apr 2021 Atlanta, Georgia, United States

HemoShear Therapeutics

Biotechnology
Health Care
Medical
$40M10 Feb 2021 Charlottesville, Virginia, United States
News
Beckley Psytech Closes $80M Series B Funding

– Beckley Psytech an Oxford, England-based private company dedicated to addressing neurological and psychiatric disorders through the novel application of psychedelic medicines closed an $80m Series B financing.
– The round was led by Integrated with participation from Prime Movers Labs, Adage Capital Management, Palo Santo; Delphi VC; Leafy Tunnel; Negev Capital; and existing investor Bicycle Day Ventures.
– The company intends to use the funds to complete the ongoing Phase 1b trial with low-dose psilocybin in patients suffering from SUNHA, a rare and debilitating headache condition estimated to affect 45,000 people in the US and Europe, and to initiate a Phase 1 dose-ranging study on a novel formulation of intranasal 5-MeO-DMT before starting a Phase 2 trial in Treatment Resistant Depression, and expand its pipeline with new, unique and proprietary psychedelic compounds.

Gopuff Raises $1 Billion in New Funding from Leading Global Investors

– Gopuff, the go-to platform for consumers’ immediate everyday needs, announced that it has secured $1 billion in new funding at a $15 billion valuation.
– Some of the world’s foremost technology investors participated in the round, including new investors Blackstone’s Horizon platform, Guggenheim Investments, Hedosophia, MSD Partners, and Adage Capital, along with existing investors Fidelity Management and Research Company, Softbank Vision Fund 1, Atreides Management, and Eldridge.
– With these new funds, Gopuff will continue to accelerate its strategic business initiatives including further geographic expansion across North America, deeper expansion into the UK and across Europe, hiring top-tier local talent, and focusing on enhancing its technology to continue to deliver an exceptional customer experience.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Adage Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 105
Average round size 94M
Rounds per year 4.57
Peak activity year 2021
Lead investments 6
Follow on index 0.18
Exits 51
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Menlo Micro

Consumer Electronics
Electronics
Hardware
Power Grid
Semiconductor
$150M09 Mar 2022 Irvine, California, United States

Scout Bio

Biotechnology
Health Care
Therapeutics
$33M19 Oct 2021 Philadelphia, Pennsylvania, United States

Pyramid Biosciences

Biotechnology
Life Science
$33M15 Oct 2021 Massachusetts, United States

Beckley Psytech

Health Care
Medical
Pharmaceutical
$79M15 Aug 2021 South Oxfordshire, England, United Kingdom

SiMa.ai

Artificial Intelligence
Machine Learning
Software
$80M11 May 2021 San Jose, California, United States

Arch Oncology

Biotechnology
$105M27 Apr 2021 California, United States

Biotechnology
Health Care
Information Technology
Pharmaceutical
Travel
$100M13 Apr 2021 New York, New York, United States

Antios Therapeutics

Biopharma
Biotechnology
Therapeutics
$96M12 Apr 2021 Atlanta, Georgia, United States

HemoShear Therapeutics

Biotechnology
Health Care
Medical
$40M10 Feb 2021 Charlottesville, Virginia, United States
Crunchbase icon

Content report

The following text will be sent to our editors: